See more : Kyowa Leather Cloth Co., Ltd. (3553.T) Income Statement Analysis – Financial Results
Complete financial analysis of Korian (0OPS.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Korian, a leading company in the industry within the sector.
- PharmAust Limited (PAA.AX) Income Statement Analysis – Financial Results
- BKV Corporation (BKV) Income Statement Analysis – Financial Results
- PT Semen Indonesia (Persero) Tbk (SMGR.JK) Income Statement Analysis – Financial Results
- HEXPOL AB (publ) (HXXPY) Income Statement Analysis – Financial Results
- Zhongxing Shenyang Commercial Building Group Co.,Ltd (000715.SZ) Income Statement Analysis – Financial Results
Korian (0OPS.L)
About Korian
Korian provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. As of December 31, 2021, it operated with 91,808 beds. The company operates approximately 850 care facilities and networks in France, Germany, Italy, Spain, the Netherlands, and Belgium. The company was formerly known as Korian-Medica S.A. and changed its name to Korian in July 2015. Korian was founded in 2001 and is based in Paris, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.00B | 4.44B | 4.14B | 3.77B | 3.61B | 3.34B | 3.13B | 2.98B | 2.57B | 2.22B | 1.36B | 1.11B |
| Cost of Revenue | 3.43B | 3.07B | 2.83B | 2.47B | 2.19B | 1.99B | 1.87B | 1.74B | 1.48B | 1.23B | 742.70M | 602.19M |
| Gross Profit | 1.57B | 1.37B | 1.30B | 1.30B | 1.42B | 1.35B | 1.26B | 1.24B | 1.09B | 987.29M | 613.67M | 506.17M |
| Gross Profit Ratio | 31.41% | 30.82% | 31.48% | 34.45% | 39.26% | 40.44% | 40.30% | 41.60% | 42.50% | 44.43% | 45.24% | 45.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 544.63M | 457.83M | 429.85M | 437.01M | 448.90M | 765.43M | 734.54M | 727.77M | 664.27M | 597.07M | 390.96M | 325.37M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.37B | 1.22B | 979.06M | 1.05B | 1.08B | 1.07B | 1.00B | 1.03B | 926.43M | 830.73M | 515.21M | 421.72M |
| Cost & Expenses | 4.80B | 4.29B | 3.81B | 3.53B | 3.27B | 3.06B | 2.87B | 2.78B | 2.41B | 2.07B | 1.26B | 1.02B |
| Interest Income | 156.20M | 195.89M | 190.31M | 187.31M | 164.07M | 100.04M | 98.43M | 88.12M | 53.25M | 49.59M | 43.29M | 31.77M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 750.31M | 239.83M | 615.76M | 556.68M | 510.64M | 163.30M | 157.03M | 155.95M | 123.83M | 98.74M | 61.70M | 44.69M |
| EBITDA | 585.68M | 907.45M | 841.76M | 760.02M | 884.90M | 467.15M | 439.81M | 394.57M | 305.61M | 297.90M | 168.70M | 120.99M |
| EBITDA Ratio | 11.72% | 20.45% | 20.35% | 20.14% | 24.50% | 14.00% | 14.05% | 13.23% | 11.88% | 13.41% | 12.44% | 10.92% |
| Operating Income | 276.16M | 252.57M | 226.00M | 203.34M | 374.25M | 303.85M | 282.78M | 238.62M | 181.78M | 199.16M | 107.00M | 76.30M |
| Operating Income Ratio | 5.53% | 5.69% | 5.46% | 5.39% | 10.36% | 9.11% | 9.03% | 8.00% | 7.06% | 8.96% | 7.89% | 6.88% |
| Total Other Income/Expenses | -359.02M | -195.39M | -92.93M | -144.06M | -198.74M | -126.21M | -120.01M | -121.04M | -67.77M | -92.18M | -51.83M | -23.62M |
| Income Before Tax | -82.86M | 57.18M | 133.07M | 59.28M | 175.51M | 177.64M | 162.77M | 117.58M | 114.01M | 106.98M | 55.18M | 52.69M |
| Income Before Tax Ratio | -1.66% | 1.29% | 3.22% | 1.57% | 4.86% | 5.32% | 5.20% | 3.94% | 4.43% | 4.81% | 4.07% | 4.75% |
| Income Tax Expense | 2.57M | 12.16M | 11.42M | 17.18M | 59.29M | 52.61M | 3.56M | 15.58M | 53.04M | 42.46M | 23.79M | 26.83M |
| Net Income | -92.44M | 35.74M | 99.88M | 39.40M | 114.68M | 123.13M | 163.32M | 131.29M | 58.69M | 61.25M | 28.58M | 23.28M |
| Net Income Ratio | -1.85% | 0.81% | 2.41% | 1.04% | 3.17% | 3.69% | 5.22% | 4.40% | 2.28% | 2.76% | 2.11% | 2.10% |
| EPS | -0.87 | 0.25 | 0.78 | 0.30 | 1.29 | 1.38 | 1.86 | 1.57 | 0.73 | 0.77 | 0.83 | 0.67 |
| EPS Diluted | -0.87 | 0.30 | 0.82 | 0.37 | 1.29 | 1.38 | 1.86 | 1.57 | 0.73 | 0.77 | 0.83 | 0.67 |
| Weighted Avg Shares Out | 106.39M | 145.81M | 128.80M | 130.73M | 88.95M | 88.95M | 87.81M | 83.63M | 79.93M | 79.40M | 34.43M | 34.49M |
| Weighted Avg Shares Out (Dil) | 106.39M | 120.46M | 122.19M | 105.78M | 88.95M | 88.95M | 87.96M | 83.80M | 80.40M | 79.55M | 34.49M | 34.74M |
Source: https://incomestatements.info
Category: Stock Reports